Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002781375 | SCV003034566 | likely benign | Nemaline myopathy 2 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004958772 | SCV005451805 | uncertain significance | Inborn genetic diseases | 2024-11-26 | criteria provided, single submitter | clinical testing | The c.1170C>G (p.N390K) alteration is located in exon 14 (coding exon 12) of the NEB gene. This alteration results from a C to G substitution at nucleotide position 1170, causing the asparagine (N) at amino acid position 390 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |